TrialInternational journal of gynecological cancer : official journal of the International Gynecological Cancer Society2020

Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study.

Dana Chase et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.